138
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Identification of rare de novo epigenetic variations in congenital disorders

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Certain human traits such as neurodevelopmental disorders (NDs) and congenital anomalies (CAs) are believed to be primarily genetic in origin. However, even after whole-genome sequencing (WGS), a substantial fraction of such disorders remain unexplained. We hypothesize that some cases of ND–CA are caused by aberrant DNA methylation leading to dysregulated genome function. Comparing DNA methylation profiles from 489 individuals with ND–CAs against 1534 controls, we identify epivariations as a frequent occurrence in the human genome. De novo epivariations are significantly enriched in cases, while RNAseq analysis shows that epivariations often have an impact on gene expression comparable to loss-of-function mutations. Additionally, we detect and replicate an enrichment of rare sequence mutations overlapping CTCF binding sites close to epivariations, providing a rationale for interpreting non-coding variation. We propose that epivariations contribute to the pathogenesis of some patients with unexplained ND–CAs, and as such likely have diagnostic relevance.

          Abstract

          A proportion of neurodevelopmental disorder and congenital anomaly cases remain without a genetic diagnosis. Here, the authors study aberrations of DNA methylation in such cases and find that epivariations might provide an explanation for some of these undiagnosed patients.

          Related collections

          Most cited references30

          • Record: found
          • Abstract: found
          • Article: not found

          High density DNA methylation array with single CpG site resolution.

          We have developed a new generation of genome-wide DNA methylation BeadChip which allows high-throughput methylation profiling of the human genome. The new high density BeadChip can assay over 480K CpG sites and analyze twelve samples in parallel. The innovative content includes coverage of 99% of RefSeq genes with multiple probes per gene, 96% of CpG islands from the UCSC database, CpG island shores and additional content selected from whole-genome bisulfite sequencing data and input from DNA methylation experts. The well-characterized Infinium® Assay is used for analysis of CpG methylation using bisulfite-converted genomic DNA. We applied this technology to analyze DNA methylation in normal and tumor DNA samples and compared results with whole-genome bisulfite sequencing (WGBS) data obtained for the same samples. Highly comparable DNA methylation profiles were generated by the array and sequencing methods (average R2 of 0.95). The ability to determine genome-wide methylation patterns will rapidly advance methylation research. Copyright © 2011 Elsevier Inc. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            SAMBLASTER: fast duplicate marking and structural variant read extraction

            Motivation: Illumina DNA sequencing is now the predominant source of raw genomic data, and data volumes are growing rapidly. Bioinformatic analysis pipelines are having trouble keeping pace. A common bottleneck in such pipelines is the requirement to read, write, sort and compress large BAM files multiple times. Results: We present SAMBLASTER, a tool that reduces the number of times such costly operations are performed. SAMBLASTER is designed to mark duplicates in read-sorted SAM files as a piped post-pass on DNA aligner output before it is compressed to BAM. In addition, it can simultaneously output into separate files the discordant read-pairs and/or split-read mappings used for structural variant calling. As an alignment post-pass, its own runtime overhead is negligible, while dramatically reducing overall pipeline complexity and runtime. As a stand-alone duplicate marking tool, it performs significantly better than PICARD or SAMBAMBA in terms of both speed and memory usage, while achieving nearly identical results. Availability and implementation: SAMBLASTER is open-source C++ code and freely available for download from https://github.com/GregoryFaust/samblaster. Contact: imh4y@virginia.edu
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              De novo mutations in human genetic disease.

              New mutations have long been known to cause genetic disease, but their true contribution to the disease burden can only now be determined using family-based whole-genome or whole-exome sequencing approaches. In this Review we discuss recent findings suggesting that de novo mutations play a prominent part in rare and common forms of neurodevelopmental diseases, including intellectual disability, autism and schizophrenia. De novo mutations provide a mechanism by which early-onset reproductively lethal diseases remain frequent in the population. These mutations, although individually rare, may capture a significant part of the heritability for complex genetic diseases that is not detectable by genome-wide association studies.
                Bookmark

                Author and article information

                Contributors
                andrew.sharp@mssm.edu
                Journal
                Nat Commun
                Nat Commun
                Nature Communications
                Nature Publishing Group UK (London )
                2041-1723
                25 May 2018
                25 May 2018
                2018
                : 9
                : 2064
                Affiliations
                [1 ]ISNI 0000 0001 0670 2351, GRID grid.59734.3c, The Mindich Child Health & Development Institute and the Department of Genetics & Genomic Sciences, , Icahn School of Medicine at Mount Sinai, ; New York, NY 10029 USA
                [2 ]ISNI 0000 0001 0670 2351, GRID grid.59734.3c, Graduate School of Biomedical Sciences, , Icahn School of Medicine at Mount Sinai, ; New York, NY 10029 USA
                [3 ]ISNI 0000 0001 0670 2351, GRID grid.59734.3c, The Seaver Autism Center for Research and Treatment, , Icahn School of Medicine at Mount Sinai, ; New York, NY 10029 USA
                [4 ]ISNI 0000 0001 2108 5881, GRID grid.418922.4, School of Theoretical and Applied Sciences, , Ramapo College of New Jersey, ; Mahwah, NJ 07430 USA
                [5 ]ISNI 0000 0001 0670 2351, GRID grid.59734.3c, Department of Genetics and Genomic Sciences, , Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, ; New York, NY 10029 USA
                [6 ]ISNI 0000 0001 0670 2351, GRID grid.59734.3c, Department of Psychiatry, , Icahn School of Medicine at Mount Sinai, ; New York, NY 10029 USA
                [7 ]ISNI 0000 0001 2159 175X, GRID grid.10328.38, ICVS/3B’s PT Government Associate Laboratory, Life and Health Sciences Research Institute, School of Medicine, , University of Minho, ; Braga/Guimarães, 4710-057 Portugal
                [8 ]ISNI 0000000122931605, GRID grid.5590.9, Radboud University Medical Center, Department of Human Genetics, , Donders Institute for Brain, Cognition and Behaviour, ; Nijmegen, 6500 HB The Netherlands
                [9 ]ISNI 0000 0001 0670 2351, GRID grid.59734.3c, The Division of Tics, OCD and Related Disorders, Department of Psychiatry, and Mindich Child Health and Development Institute, , Icahn School of Medicine at Mount Sinai, ; New York, NY 10029 USA
                [10 ]ISNI 0000 0001 0670 2351, GRID grid.59734.3c, The Friedman Brain Institute, , Icahn School of Medicine at Mount Sinai, ; New York, NY 10029 USA
                [11 ]Center for Medical Genetics Dr. Jacinto Magalhães, Porto Hospital Center, Porto, 4050-106 Portugal
                [12 ]Maastricht University Medical Center, Department of Clinical Genetics, GROW School for Oncology and Developmental Biology, Maastricht, 6229 HX The Netherlands
                [13 ]ISNI 0000 0001 0670 2351, GRID grid.59734.3c, Department of Pediatrics, , Icahn School of Medicine at Mount Sinai, ; New York, NY 10029 USA
                [14 ]GRID grid.428467.b, Cardiogenetic Program, GeneDx, Inc., ; Gaithersburg, MD 20877 USA
                Author information
                http://orcid.org/0000-0002-4253-3097
                http://orcid.org/0000-0001-8527-5027
                Article
                4540
                10.1038/s41467-018-04540-x
                5970273
                29802345
                c074eb75-9252-4aed-bf5a-d8429fffb9ab
                © The Author(s) 2018

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 29 August 2017
                : 8 May 2018
                Categories
                Article
                Custom metadata
                © The Author(s) 2018

                Uncategorized
                Uncategorized

                Comments

                Comment on this article